Heidi S. Harvie, MD, MBA, MSCE
she/her/hers
Urogynecology
Accepting new patients
Sees patients age 18 and up
Penn Urogynecology Washington Square
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Director, Penn Urogynecology & Pelvic Reconstructive Surgery, Pennsylvania Hospital
  • Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

491 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
i've met dr. harvie twice. on the basis of those visits, i am ready to now have complicated surgery that i've been putting off since at least 2012.
Anonymous
April 2026
easy to talk to and very thorough
Anonymous
April 2026
great doctor
Anonymous
April 2026
she doesn't inform patients ahead of time when she is not coming to an appointment that was scheduled with her.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Harvie is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Gilmore E, McAllister A, Russell LB, Montoya M, Koelper NC, Schreiber CA, Harvie HS Validity and Responsiveness of EQ-5D-5L in the Abortion Care Setting , American journal of obstetrics and gynecology, 234(4): 2026,1121–1129

Agrawal, S., Ikpeama, N., Koelper, N., Dokras, A., Harvie, H., Hamm, R. F., Dutcher, L., & Arya, L. A. A Randomized Trial of a Texting Platform for Recurrent Urinary Tract Infections , Urogynecology, 32(3): 2026,62–171

Lukacz ES, Menefee SA, Carper B, Collins S, McMillian K, Florian-Rodriguez M, Rardin C, Weidner AC, Harvie HS, Alexander B, Mazloomdoost D, NICHD Pelvic Floor Disorders Network Design of Transurethral Bulking Agent Injection Versus Single-Incision SlingTrial , Urogynecology , 32(2): 2026,131–141

Harvie HS, Chermansky C, Richter HE Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply , JAMA, 334(16): 2025,1488-1489

Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS Variation in Overactive Bladder Treatment Type by Social Determinants of Health. , Urogynecology, 31(10): 2025,929-941

Walter JR, Richards EG, Johannesson L, Falcone T, Testa G, O'Neill KE, Harvie HS Cost-effectiveness Analysis of Uterus Transplantation versus Gestational Carrier for Treatment of Absolute Uterine Factor Infertility. , Fertil Steril, 124(1): 2025,121-133

Reaves S, Levin, PJ, Harvie HS, Andy UU Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. , Int Urogynecol J, 36(7): 2025,1457-1463

Harvie HS, Menefee SA, Richter HE, Sung VW, Chermansky CJ, Rahn DD, Amundsen CL, Arya LA, Rhodes E, Mazloomdoost D, Thomas S, National Institute of Child Health and Human Development Pelvic Floor Disorders Network Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial. , JAMA, 333(21): 2025,1887-1896

Arya LA, Agrawal S, Ikpeama N, Harvie HS, Feldman RH, Dutcher L Implementing a Digital Platform for Recurrent Urinary Tract Infections , Urogynecology , 31(3): 2025,183-193

CX Hong, M O'Leary, W Horner, PC Schmidt, HS Harvie, NS Kamdar, DM Morgan Decreasing Utilization of Vaginal Hysterectomy in the United States: An Analysis by Candidacy for Vaginal Approach , Int Urogynecol J, 35(10): 2024,1983-1991